Pharmacopoeial impurityDinoprostone EP Impurity CCat. No. P-D136-002CAS 36150-00-2Family · Pharmaceutical analytical standards
Dinoprostone
It is prostaglandin E2, a molecule our body also makes, used as a medicine mainly to ripen the cervix and induce labour. It has been approved in the United States since 1977 and is on the WHO List of Essential Medicines. This family brings together pharmacopoeial impurities.
Did you know?Prostaglandins were discovered in 1935 in human seminal fluid; PGE2 itself was identified in 1962 by Swedish biochemist Sune Bergström in sheep seminal fluid.
Pharmacopoeial impurityDinoprostone EP Impurity CCat. No. P-D136-002CAS 36150-00-2
Pharmacopoeial impurityDinoprostone EP Impurity BCat. No. P-D136-003CAS 27415-25-4
Pharmacopoeial impurityDinoprostone EP Impurity DCat. No. P-D136-004CAS 13345-50-1
Pharmacopoeial impurityDinoprostone EP Impurity ECat. No. P-D136-005CAS 71431-28-2
Pharmacopoeial impurityDinoprostone EP Impurity FCat. No. P-D136-006CAS 26441-05-4No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceDinoprostone CRSEDQM code D2250000Family DinoprostoneImpurityDinoprostone impurity C CRSEDQM code D2250015Family DinoprostoneNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.